A review article on the dosimetry in intraluminal HDR brachytherapy of lung carcinoma

• Published in: Journal of cancer research and therapeutics 2023-04, Vol.19 (8), p.36-40
• Main Authors: Kant, Ravi, Gupta, Meenu, Bisht, Jyoti, Nautiyal, Vipul, Kumar, Viney, Dobhal, Rishabh, Ahmed, Mushtaq, Saini, Sunil
• Format: Article
• Language: English
• Subjects: Brachytherapy - methods; Carcinoma; Computer Simulation; Dosimetry; Humans; Lung; Lung cancer; Lung Neoplasms - radiotherapy; Monte Carlo Method; Phantoms, Imaging; Radiation therapy; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted - methods
• ISSN: 0973-1482; 1998-4138
• DOI: 10.4103/jcrt.jcrt_541_22

Lung cancer is one of the most common cancers in the world. Intraluminal brachytherapy (BT) is one of the most adopted treatment modalities for lung malignancies with Ir-192 source in radiotherapy. In intraluminal BT, treatment delivery is required to be very accurate and precise with respect to the plan created in the treatment planning system (TPS). The BT dosimetry is necessary for better treatment outcomes. Therefore in this review article, some relevant studies were identified and analyzed for dosimetric outcomes in intraluminal BT in lung malignancies. The dosimetry in BT for plan verification is not presently in practice, which needs to be performed to check the variation between the planned and measured doses. The necessary dosimetric work done by the various researchers in intraluminal BT such as the Monte Carlo CYLTRAN code was used to calculate and measure the dose rate in any medium. Anthropomorphic phantom was used to measure doses at some distance from the source with Thermo luminescence dosimeters (TLDs). The dosimetric influence of air passage in the bronchus was evaluated with the GEANT4 Monte Carlo method. A pinpoint chamber was used to measure and quantify the impact of inhomogeneity in wax phantom for the Ir-192 source. The Gafchromic films and Monte Carlo methods were used to find the phantom and heterogeneities, which were found to underestimate the dose for the lungs and overestimated for the bones in TPS. The exact tool to quantify the variation in planned and delivered doses should be cost-effective and easy to use possibly with tissue equivalent phantoms and Gafchromic films in lung malignancies treatment.